Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Voi supports Road Safety Week to encourage safe winter riding

Above: Road Safety Week graphic Credit: Brake Friday 17 November 2023, UK: Voi, the UK’s leading micromobility operator, is supporting Road Safety Week 2023 by encouraging its riders to stay safe this winter.From 19-25 November, road safety charity Brake holds its annual week of road safety awareness-raising. Voi will be reminding riders to ride safely by sharing advice from Brake as well as its own top tips for safe and considerate e-scooter riding across its channels. Voi’s top tips for riding safely and sustainably this winter include:  1. Turn on the ‘Beginner’

Careium ranked as number one on substantial UK framework

Careium has been awarded a significant contract for the supply of telecare equipment as part of a re-tendered framework agreement. It covers the requirements of Leeds City Council and Kirklees Council, Wakefield Metropolitan District Council, East Riding of Yorkshire Council, City of Bradford Metropolitan District Council, Calderdale Metropolitan Borough Council and Middlesborough Council. The framework will provide telecare equipment that will promote and maintain the independence and well-being of residents who require such support. The tender included a rigorous assessment of products,

MyFirstApp Sweden AB (publ) Interim Report 3 - 2023

Financial overview +-----------------------------+-------+-------+----------+----------+----------+|Consolidated income statement|Q3 2023|Q3 2022|Q1-Q3 2023|Q1-Q3 2022|Helår 2022|+-----------------------------+-------+-------+----------+----------+----------+|Net revenue (msek) |0,6 |0 |1,5 |0 |0,4 |+-----------------------------+-------+-------+----------+----------+----------+|EBITDA (msek) |−0,2 |0 |−1,8 |0 |0 |+-----------------------------+-------+-------+----------+----------+----------+

Transcom partners with Netomi to set a new standard in customer experience

Transcom, a global leader in digital Customer Experience (CX) is proud to announce a strategic partnership with Netomi, a pioneering leader in Artificial Intelligence (AI) for CX, to unleash the power of GenAI at scale in the customer experience industry. At the center of this partnership are Transcom’s global customers that include a combination of innovative scale-ups and globally recognized enterprise brands, who collectively have over 300,000 customer support agents. This dynamic partnership sets a new standard in customer experience excellence by empowering agents with field-proven AI

BoMill Q3 Report July – September 2023

BoMill AB (”BoMill” or the “Company”) hereby publishes the Interim Report for the period July 1 – September 30, 2023. The Interim Report is available as an attached file to this release and on BoMill’s website. Below is a summary of the report.Focus on commercial development – new orders and strategic partnerships CEO Andreas Jeppsson comments: “A new order on BoMill InSight™ and new partnerships with leading companies expanding our distribution network in strategic markets, is the result of our intense commercial activities and the success of our first BoMill InSight™ installations.”

Pharmacolog publishes interim report January - September 2023

Pharmacolog i Uppsala AB (publ) announces today that the interim report for the period January – September 2023 has been published.The annual report is attached as a PDF and is available on the company’s website:https://pharmacolog.com/investor-relations-2/financial-reports/ (Swedish only). Third quarter July 1 - September 30, 2023Consolidated net sales for the third quarter amounted to KSEK 1 361 (3 087).The operating result for the quarter amounted to KSEK -4,418 (-3,246).Net earnings per share for the quarter were SEK -0.07 (-0.20) before dilution and SEK -0.04 (-0.19) after

LEAX Interim Financial Report Q3 2023

Quarterly results lower but strategic momentum continuesThe third quarter in summary •                           Net Sales increased to SEK 457.9 million (445.9) •                           Operating profit decreased to SEK -12.6 million (-5.7) •                           Earnings before tax (EBT) decreased to SEK -30.3 million (-12.5) •                           Net income for the period decreased to SEK -33.1 million (-16.4) •                           Cash flow from operating activities amounted to SEK 20.1 million (17.2) The first nine months in summary •

CLS publishes interim report January – September 2023

Summary of the interim report (relates to the Group)   First nine months (01/01/2023–09/30/2023) · Net sales totaled SEK 3,817,000 (SEK 1,973,000). · Profit/loss after financial items totaled SEK –55,227,000 (SEK -62,192,000). · Basic and diluted earnings per share totaled SEK -0.12 (SEK -0.9). · The equity ratio at September 30, 2023, was 86% (34%).   The third quarter (07/01/2023 – 09/30/2023) · Net sales totaled SEK 1,978,000 (SEK 884,000). · Profit/loss after financial items totaled SEK –17,247,000 (SEK -30,374,000). · Basic and diluted earnings per

Cereno Scientific publishes the interim report for Q3 2023 (July 1 – September 30)

The Board and Chief Executive Officer of Cereno Scientific AB here present the interim report for Q3 2023 (July 1 – September 30).Summary of the interim report for Q3 2023 (July 1 – September 30) Cereno Scientific Group · Result after financial items was SEK -11,076,974 (-7,248,364) · Earnings per share was SEK -0.05 (-0.06) before dilution and SEK -0.05 (-0.04) after dilution · The equity/assets ratio was 95.4% (93.2%) · Cash and bank balance was SEK 68,455,542 SEK (36,569,272) Parent company · Result after financial items was SEK -11,076,973 (-7,215,192) ·

Interim Report January - September 2023

The quarter in brief Jul 1st – Sep 30th Jan 1st – Sep 30th 20232023 · Net sales amounted to EUR 11 333 · Net sales amounted thousandto EUR 3 749 thousand (EUR 18 693 thousand in same period last(EUR 5 794 thousand in year)Q3 last year) · EBITDA of EUR 1 158 thousand (EUR 389 · EBITDA of EUR 564 thousand) and EBITDA margin of 10.2%thousand (EUR 24 (2.1%)thousand) and EBITDA · EBIT of EUR 1 050 thousand (75) andmargin of 15% (0.4%) EBIT margin of 9.3% (0.4%) · EBIT

BioStock: Respiratorius’ CEO: “Strong belief but patience regarding agreement”

Lund-based Respiratorius continues talks to reach an agreement regarding the drug candidate VAL001. The discussions are now focused on already established contacts, the company states in its newly released Q3 report. When BioStock contacted CEO Johan Drott to get his view of the past quarter, he was hopeful of reaching an agreement.Read the full article at biostock.se : https://www.biostock.se/en/2023/11/respiratorius-ceo-strong-belief-but-patience-regarding-agreement/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital17 November 2023 at 9.15 EET Nordea has today cancelled 13,500,394 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. The cancellation brings the total number of shares in Nordea to 3,535,389,326. The total number of votes attached to the shares is 3,535,389,326. The cancellation of the shares was registered with the Finnish Trade Register on 17 November 2023. The company holds 588,029

Assemblin wins a multi-technical installation assignment in a new R&D facility in Lund

Assemblin has been contracted by Skanska to design and install electrical, heating, water, cooling and gas technology in a new R&D facility in Lund (the Höjdpunkten 5 property). The value of the installation assignment is estimated at SEK 85 million.On behalf of property company Vectura, Skanska is to build a new facility of approximately 24,000 m[2] with offices, a laboratory and a test environment. Groundwork has begun and the buildings are scheduled for completion late 2025. Skanska has contracted Assemblin to assume responsibility for the electrical and heating & sanitation

Fortum and Studsvik partner to explore possibilities for new nuclear in Sweden

FORTUM CORPORATION PRESS RELEASE 17.11.2023  Fortum and the Swedish nuclear technology company Studsvik have signed a Memorandum of Understanding (MoU) to explore conditions for new nuclear in Sweden. The collaboration is part of Fortum’s ongoing feasibility study to explore business opportunities in new nuclear both in Finland and Sweden.  The agreement supports Fortum’s strategic priorities to deliver reliable and clean energy and to drive decarbonisation in industries by providing clean energy and CO2-free solutions to its customers.  “A lot of new electricity generation will be

Implantica presents the third quarter 2023 on November 22 at 15:00 CET

Implantica AG (publ) invites investors to a presentation of the third quarter 2023 at 15:00 CET on November 22. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.The presentation will be in English via an audiocast with teleconference: If you wish to participate via webcast, please use the following link: · https://ir.financialhearings.com/implantica-q3-2023 If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the

Truqap approved in US for HR+ breast cancer

17 November 2023 Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients with specific biomarker alterations (PIK3CA, AKT1 or PTEN) Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in the biomarker-altered population AstraZeneca's Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of

NCC builds new treatment plant in Österåker, Sweden

NCC has been contracted by Roslagsvatten to build a new treatment plant in Österåker to secure wastewater treatment for Österåker Municipality and the City of Vaxholm. The work will be carried out as a turnkey contract and the order value is approximately SEK 1.2 billion. Image: Skoog Arkitekter On behalf of Roslagsvatten, NCC will build a new wastewater treatment plant alongside the existing one in Margretelund, Åkersberga. Preliminary works have been ongoing for some time and the project is now entering its next phase. This includes advanced work with special ground

Wicket Gaming AB changes its name to edyoutec AB

Wicket Gaming AB (publ) (the "Company") has completed the name change to edyoutec AB, which was voted through at the Extraordinary General Meeting held on 7 November 2023.The company is still listed on Spotlight Stock Market but will go under the name edyoutec. The share will be traded under the name edyoutec with the ticker EDYOU as of 23 November 2023. The new FSIN code is EDYOUTEC/SH.   For further information, please contact: Eric de Basso, CEO, Wicket Gaming ABE-mail: eric@wicketgaming.com  Phone: +46 70 780 52 00 About Wicket GamingWicket Gaming is a Swedish game

Neste and Mitsui Chemicals Group enable food packaging made with renewable materials for CO-OP brand in Japan

Neste Corporation, Press Release, 17 November 2023 at 9.00 a.m. (EET) Photo: CO-OP’s seaweed snack now comes in plastic packaging made with renewable materials. Source: JCCU. · Cooperation enables seaweed snack packaging made with renewable raw materials, further applications planned · First packaging made with renewable plastics via mass balancing that has received the Japanese Eco Mark certification Neste, Mitsui Chemicals and Prime Polymer, a subsidiary of Mitsui Chemicals, are working together to provide more sustainable food packaging solutions for CO-OP, a brand of

Safello Publishes Interim Report for Third Quarter 2023

Stockholm, 17 November 2023 | Today, Safello Group AB (“Safello”) publishes the company’s interim report for the third quarter (1 July–30 September) 2023. The report can be found on safello.com/ir . In the third quarter, there has been stable activity with end of year tailwinds with Swish and Police Authority procurement.  Summary of the third quarter (July–September 2023) · Net turnover decreased by -17% and amounted to SEK 115.3 million (138.8).  · Gross profit decreased by -19% and amounted to SEK 7.3 million (9.0).  ·

Samhällsbyggnadsbolaget i Norden AB’s Nomination Committee appointed

Samhällsbyggnadsbolaget i Norden AB (publ) Nomination Committee for the Annual General Meeting 2024 has been appointed in accordance with the Instruction for the Nomination Committee resolved by the Annual General Meeting 2023. The Nomination Committee consists of: · Ilija Batljan (Ilija Batljan Invest AB) · Rikard Svensson (AB Arvid Svensson) · Leif West (Dragfast AB) · Sven-Olof Johansson (Compactor Fastigheter AB) · Lennart Schuss (the Chair of the Board of Directors) Leif West is the Chair of the Nomination Committee. Shareholders who wish to submit proposals

Studsvik and Fortum partner to explore the possibilities for new nuclear

Studsvik, a nuclear technology company providing safety and efficiency for the global nuclear industry, have signed a Memorandum of Understanding (MoU) with Fortum, a Nordic energy company, to explore the conditions for new nuclear at the Studsvik site outside Nyköping in Sweden.Studsvik wants to support the climate transition, where more nuclear power is needed to meet the climate goals, while also satisfying the increasing demand for energy in all parts of the world. In the long term there is a possibility for new nuclear power on the Studsvik site, either in the form of commercial

There are no items matching the current filter
There are no more items matching the current filter
Back to top